Induction of Paracrine Signaling in Metastatic Melanoma Cells by PPARγ Agonist Rosiglitazone Activates Stromal Cells and Enhances Tumor Growth
- 15 November 2018
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 78 (22) , 6447-6461
Abstract
In addition to improving insulin sensitivity in type 2 diabetes, the thiazolidinedione family of compounds and the pharmacologic activation of their best-characterized target PPARγ have been proposed as a therapeutic option for cancer treatment. In this study, we reveal a new mode of action for the thiazolidinedione rosiglitazone that can contribute to tumorigenesis. Rosiglitazone activated a tumorigenic paracrine communication program in a subset of human melanoma cells that involves the secretion of cytokines, chemokines, and angiogenic factors. This complex blend of paracrine signals activated nonmalignant fibroblasts, endothelial cells, and macrophages in a tumor-friendly way. In agreement with these data, rosiglitazone promoted human melanoma development in xenografts, and tumors exposed to rosiglitazone exhibited enhanced angiogenesis and inflammation. Together, these findings establish an important tumorigenic action of rosiglitazone in a subset of melanoma cells. Although studies conducted on cohorts of diabetic patients report overall benefits of thiazolidinediones in cancer prevention, our data suggest that exposure of established tumors to rosiglitazone may be deleterious.Significance: These findings uncover a novel mechanism by which the thiazolidinedione compound rosiglitazone contributes to tumorigenesis, thus highlighting a potential risk associated with its use in patients with established tumors. Cancer Res; 78(22); 6447–61. ©2018 AACR.Keywords
All Related Versions
Funding Information
- Swiss National Science Foundation (FN31003A_169232)
- Swiss Cancer League (KFS-2900-02-2012)
- Fondation Pierre Mercier pour la Sciences
- Etat de Vaud
- Swiss Foundation for Excellence and Talent in Biomedical Research
- Swiss National Science Foundation (31003A_156469)
- Swiss National Science Foundation (Ambizione PZOOP3_1614590)
This publication has 47 references indexed in Scilit:
- WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013Nucleic Acids Research, 2013
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012
- Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to ResistanceCancer Cell, 2012
- Activation of PPARγ in Myeloid Cells Promotes Lung Cancer Progression and MetastasisPLOS ONE, 2011
- Constitutive Aberrant Endogenous Interleukin-1 Facilitates Inflammation and Growth in Human MelanomaMolecular Cancer Research, 2011
- Cohort Study of Pioglitazone and Cancer Incidence in Patients With DiabetesDiabetes Care, 2011
- Integrative Genome Comparison of Primary and Metastatic MelanomasPLOS ONE, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Fat and Beyond: The Diverse Biology of PPARγAnnual Review of Biochemistry, 2008
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971